Repro Med Systems Inc (KRMD) - Total Liabilities
Based on the latest financial reports, Repro Med Systems Inc (KRMD) has total liabilities worth $11.67 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Repro Med Systems Inc to track the company's year-over-year net asset growth rate.
Repro Med Systems Inc - Total Liabilities Trend (1996–2025)
This chart illustrates how Repro Med Systems Inc's total liabilities have evolved over time, based on quarterly financial data. See Repro Med Systems Inc (KRMD) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Repro Med Systems Inc Competitors by Total Liabilities
The table below lists competitors of Repro Med Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Korea Information & Communications Co. Ltd
KQ:025770
|
Korea | ₩287.10 Billion |
|
Studsvik AB
ST:SVIK
|
Sweden | Skr618.90 Million |
|
Europen Endustri Insaat Sanayi ve Ticaret A.S.
IS:EUREN
|
Turkey | TL4.12 Billion |
|
AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIRO
|
USA | $35.03 Million |
|
Genomictree Inc.
KQ:228760
|
Korea | ₩5.45 Billion |
|
Kizilbuk Gayrimenkul Yatirim Ortakligi AS
IS:KZBGY
|
Turkey | TL10.62 Billion |
|
Ador Welding Limited
NSE:ADORWELD
|
India | Rs1.87 Billion |
|
Petrus Resources Ltd
TO:PRQ
|
Canada | CA$171.78 Million |
Liability Composition Analysis (1996–2025)
This chart breaks down Repro Med Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Repro Med Systems Inc market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Repro Med Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Repro Med Systems Inc (1996–2025)
The table below shows the annual total liabilities of Repro Med Systems Inc from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $11.15 Million | +7.18% |
| 2024-12-31 | $10.40 Million | +28.34% |
| 2023-12-31 | $8.11 Million | -26.34% |
| 2022-12-31 | $11.01 Million | +129.69% |
| 2021-12-31 | $4.79 Million | +27.38% |
| 2020-12-31 | $3.76 Million | +42.19% |
| 2019-12-31 | $2.65 Million | +67.01% |
| 2018-12-31 | $1.58 Million | -1.67% |
| 2017-12-31 | $1.61 Million | +7.83% |
| 2016-12-31 | $1.49 Million | +5.03% |
| 2015-12-31 | $1.42 Million | +41.18% |
| 2014-12-31 | $1.01 Million | -0.90% |
| 2013-12-31 | $1.02 Million | -17.71% |
| 2012-12-31 | $1.24 Million | -1.50% |
| 2011-12-31 | $1.25 Million | +31.13% |
| 2010-12-31 | $956.63K | -29.51% |
| 2009-12-31 | $1.36 Million | -15.47% |
| 2008-12-31 | $1.61 Million | -9.93% |
| 2007-12-31 | $1.78 Million | -0.11% |
| 2006-12-31 | $1.78 Million | +20.01% |
| 2005-12-31 | $1.49 Million | +6.72% |
| 2004-12-31 | $1.39 Million | +2.31% |
| 2003-12-31 | $1.36 Million | +29.75% |
| 2002-12-31 | $1.05 Million | -1.17% |
| 2001-12-31 | $1.06 Million | +41.76% |
| 2000-12-31 | $749.03K | -18.29% |
| 1999-12-31 | $916.66K | -48.50% |
| 1998-12-31 | $1.78 Million | -17.59% |
| 1997-12-31 | $2.16 Million | +83.05% |
| 1996-12-31 | $1.18 Million | -- |
About Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropath… Read more